Utilizing the protein corona around silica nanoparticles for dual drug loading and release.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nanoscale

• Publication date

  2015-10-02

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1039/c5nr04726aPMID 26377025
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomolecular Coronas Provide the Biological Identity of Nanomaterials

  2017cited by this paper
• Modulation of Silica Nanoparticle Uptake into Human Osteoblast Cells by Variation of the Ratio of Amino and Sulfonate Surface Groups: Effects of Serum

  2015cited by this paper
• Amino acid-catalyzed seed regrowth synthesis of photostable high fluorescent silica nanoparticles with tunable sizes for intracellular studies

  2015cited by this paper
• Induced shape controllability by tailored precursor design in thermal and microwave-assisted synthesis of $$\mathrm{Fe}_{3}\mathrm{O}_{4}$$Fe3O4 nanoparticles

  2015cited by this paper
• Protein corona formation around nanoparticles – from the past to the future

  2014cited by this paper
• Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice

  2014cited by this paper
• Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity

  2014cited by this paper
• Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines.

  2013cited by this paper
• Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release.

  2013cited by this paper
• Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.

  2013cited by this paper
• Gold nanoparticle-protein agglomerates as versatile nanocarriers for drug delivery.

  2013cited by this paper
• Cellular effects of manufactured nanoparticles: effect of adsorption ability of nanoparticles

  2013cited by this paper
• Physicochemical properties of protein-coated gold nanoparticles in biological fluids and cells before and after proteolytic digestion.

  2013cited by this paper
• Exploiting the protein corona around gold nanorods for loading and triggered release.

  2012cited by this paper
• Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona.

  2012cited by this paper
• A chemical approach for cell-specific targeting of nanomaterials: small-molecule-initiated misfolding of nanoparticle corona proteins.

  2012cited by this paper
• Preparation of folate-conjugated pluronic F127/chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment

  2012cited by this paper
• Impact of the nanoparticle-protein corona on colloidal stability and protein structure.

  2012cited by this paper
• Orientation of human osteoblasts on hydroxyapatite-based microchannels.

  2012cited by this paper
• Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes.

  2012cited by this paper
• Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".

  2012cited by this paper
• Biomolecular coronas provide the biological identity of nanosized materials.

  2012cited by this paper
• Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics.

  2011cited by this paper
• Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles.

  2011cited by this paper
• Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.

  2011cited by this paper
• Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.

  2011cited by this paper
• Binding of blood proteins to carbon nanotubes reduces cytotoxicity

  2011cited by this paper
• Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies

  2011cited by this paper
• Effect of gold nanoparticle aggregation on cell uptake and toxicity.

  2011cited by this paper
• Protease-promoted drug delivery using peptide-functionalized gold nanoparticles

  2011cited by this paper
• Uptake and intracellular localization of submicron and nano-sized SiO2 particles in HeLa cells

  2011cited by this paper
• Protein-nanoparticle interactions: opportunities and challenges.

  2011cited by this paper
• Gold nanoparticles: dispersibility in biological media and cell-biological effect

  2010cited by this paper
• In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

  2010cited by this paper
• Time evolution of the nanoparticle protein corona.

  2010cited by this paper
• What the cell "sees" in bionanoscience.

  2010cited by this paper
• Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods.

  2010cited by this paper
• The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.

  2010cited by this paper
• Enhancement of in vitro translation by gold nanoparticle--DNA conjugates.

  2010cited by this paper
• Effective antiproliferative effect of meloxicam on prostate cancer cells: development of a new controlled release system.

  2010cited by this paper
• Protein-nanoparticle interactions: What does the cell see?

  2009cited by this paper
• Intracellular processing of proteins mediated by biodegradable polyelectrolyte capsules.

  2009cited by this paper
• Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

  2009cited by this paper
• Cathepsin L digestion of nanobioconjugates upon endocytosis.

  2009cited by this paper
• Synthesis and characterization of functionalized rhodamine B-doped silica nanoparticles

  2009cited by this paper
• Understanding biophysicochemical interactions at the nano-bio interface.

  2009cited by this paper
• Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

  2008cited by this paper
• Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.

  2008cited by this paper
• Noninvasive monitoring of intracellular pH change induced by drug stimulation using silica nanoparticle sensors

  2007cited by this paper
• Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells.

  2007cited by this paper
• Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

  2007cited by this paper
• The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century.

  2007cited by this paper
• Low density multiparticulate system for pulsatile release of meloxicam.

  2006cited by this paper
• In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells.

  2006cited by this paper
• Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

  2006cited by this paper
• Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.

  2006cited by this paper
• Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.

  2006cited by this paper
• A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells

  2006cited by this paper
• Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin

  2006cited by this paper
• Mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with serum albumin.

  2005cited by this paper
• Cyclooxygenase-independent down-regulation of multidrug resistance–associated protein-1 expression by celecoxib in human lung cancer cells

  2005cited by this paper
• Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.

  2005cited by this paper
• Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells.

  2005cited by this paper
• Nanoparticle-Aptamer Bioconjugates

  2004cited by this paper
• Folate receptor targeted biodegradable polymeric doxorubicin micelles.

  2004cited by this paper
• In vivo cancer targeting and imaging with semiconductor quantum dots

  2004cited by this paper
• Evaluation of An Aerosolized Selective COX-2 Inhibitor as a Potentiator of Doxorubicin in a Non-Small-Cell Lung Cancer Cell Line

  2003cited by this paper
• Mechanisms of cancer drug resistance.

  2002cited by this paper
• Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer.

  2001cited by this paper
• Chitosan nanoparticles as delivery systems for doxorubicin.

  2001cited by this paper
• The efflux of anthracyclines in multidrug-resistant cell lines.

  1993cited by this paper

• CD47 peptide-albumin cloaked mesoporous silica nanoparticles for enhanced macrophage evasion and synergistic combination therapy

  2026cites this paper
• Smart Nanoformulations for Oncology: A Review on Overcoming Biological Barriers with Active Targeting, Stimuli-Responsive, and Controlled Release for Effective Drug Delivery.

  2026cites this paper
• Protein Corona Modulated Doxorubicin Loading and Release from Catechin-Functionalized Ag-Au Alloy Nanoparticles.

  2025cites this paper
• Pre-programming the protein corona: From avoidance to endogenous targeting.

  2025cites this paper
• Detailed Profiling of Protein Corona Formed by Polydopamine Nanoparticles in Human Plasma.

  2025cites this paper
• Fundamental Understanding of Bio-Nano Interface of Lysozyme on Psidium guajava Polyphenol Coated Silver Nanoparticles: Mechanistic Insights into the Effect of Protein Corona on the Antibacterial Efficacy.

  2025cites this paper
• Understanding the role of biomolecular coronas in human exposure to nanomaterials

  2024cites this paper
• The role of lysosomes in airborne particulate matter-induced pulmonary toxicity.

  2024cites this paper
• Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy.

  2022cites this paper
• Co-delivery of STAT3 siRNA and methotrexate in breast cancer cells

  2022cites this paper
• Exploring the interactions between protein coronated CdSe quantum dots and nanoplastics

  2021cites this paper
• Biomolecular Corona Associated with Nanostructures: The Potentially Disruptive Role of Raman Microscopy

  2021cites this paper
• Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers.

  2020cites this paper
• Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona

  2020cites this paper
• Exploiting the protein corona: coating of black phosphorus nanosheets enables macrophage polarization via calcium influx.

  2020cites this paper
• Selective Targeting of Lymphoma Cells by Monoclonal Antibody Grafted onto Zwitterionic‐Functionalized Nanoparticles

  2020cites this paper
• Isolation methods for particle protein corona complexes from protein-rich matrices

  2020cites this paper
• Targeting Tumorigenicity of Breast Cancer Stem Cells Using SAHA/Wnt-b Catenin Antagonist Loaded Onto Protein Corona of Gold Nanoparticles

  2020cites this paper
• Nanotechnology in Regenerative Medicine and Drug Delivery Therapy

  2020cites this paper
• "Dual-Key-and-Lock" dual drug carrier for dual mode imaging guided chemo-photothermal therapy.

  2020cites this paper
• Inhaled nanoparticles-An updated review.

  2020cites this paper
• Understanding the relevance of protein corona in nanoparticle-based therapeutics and diagnostics

  2020cites this paper
• Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators

  2020cites this paper
• Protein Corona of Nanoparticles and Its Application in Drug Delivery

  2020cites this paper
• Utilizing corona on functionalized selenium nanoparticles for loading and release of doxorubicin payload

  2019cites this paper
• The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine

  2018cites this paper
• Dual Functionalization of Nanoparticles for Generating Corona-Free and Noncytotoxic Silica Nanoparticles.

  2018cites this paper
• Bimetallic gold nanorods with enhanced biocorona formation for doxorubicin loading and sustained release.

  2018cites this paper
• Human serum albumin corona on functionalized gold nanorods modulates doxorubicin loading and release

  2018cites this paper
• Nanoengineered silica: Properties, applications and toxicity.

  2017cites this paper
• Co-delivery of cisplatin and doxorubicin from calcium phosphate beads/matrix scaffolds for osteosarcoma therapy.

  2017cites this paper
• Polymer-KLAK Peptide Conjugates Induce Cancer Cell Death through Synergistic Effects of Mitochondria Damage and Autophagy Blockage.

  2017cites this paper
• Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid.

  2016cites this paper
• MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases

  2016cites this paper
• Enhancing Cellular Uptake and Doxorubicin Delivery of Mesoporous Silica Nanoparticles via Surface Functionalization: Effects of Serum.

  2015cites this paper